adagrasib
Mirati heads for FDA verdict on KRAS drug with new data
Phil Taylor
adagrasib, Amgen, asco, KRAS, Lumakras, Mirati, Non-small cell lung cancer
0 Comment
X
Mirati heads for FDA verdict on KRAS drug with new data
https://pharmaphorum.com/news/mirati-heads-for-fda-verdict-on-kras-drug-with-new-data/